These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1989 related items for PubMed ID: 24817606

  • 1. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X, Zhang H, Zhang J, Zhao S, Zheng X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y, Zhang J.
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
    Zheng J, Wang W, Yu F, Dong P, Chen B, Zhou MT.
    Cell Physiol Biochem; 2018 Sep; 46(1):82-92. PubMed ID: 29587268
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide.
    Zou Y, Cai Y, Lu D, Zhou Y, Yao Q, Zhang S.
    Cell Signal; 2017 Nov; 39():1-8. PubMed ID: 28739486
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J, Yu Y, Li S, Liu Y, Zhou S, Cao S, Yin J, Li G.
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.
    Marquez-Aguirre A, Sandoval-Rodriguez A, Gonzalez-Cuevas J, Bueno-Topete M, Navarro-Partida J, Arellano-Olivera I, Lucano-Landeros S, Armendariz-Borunda J.
    J Gene Med; 2009 Mar; 11(3):207-19. PubMed ID: 19189315
    [Abstract] [Full Text] [Related]

  • 18. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM, Li TH, Yun H, Ai HW, Zhang KH.
    Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
    [Abstract] [Full Text] [Related]

  • 19. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z, Yi J, Ye R, Liu J, Duan Q, Xiao J, Liu F.
    Int J Clin Exp Pathol; 2015 Jun; 8(4):3994-4000. PubMed ID: 26097586
    [Abstract] [Full Text] [Related]

  • 20. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Lee JH, Jang EJ, Seo HL, Ku SK, Lee JR, Shin SS, Park SD, Kim SC, Kim YW.
    Chem Biol Interact; 2014 Dec 05; 224():58-67. PubMed ID: 25451574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 100.